H2A (CIT-013 Biosimilar Antibody)重組單克隆抗體是一款專門用于科研領(lǐng)域的生物制劑。該產(chǎn)品通過基因工程技術(shù)制備，由重組DNA編碼的免疫球蛋白分子構(gòu)成，具有高特異性和均一性的特點。 作為科研工具，H2A (CIT-013 Biosimilar Antibody)重組單克隆抗體可廣泛應(yīng)用于多種實驗場景，包括蛋白質(zhì)檢測、細(xì)胞分選、酶聯(lián)免疫吸附測定（ELISA）等免疫學(xué)實驗。其高度純化的特性確保了實驗結(jié)果的可靠性和可重復(fù)性，為生命科學(xué)研究提供了穩(wěn)定的試劑支持。 該抗體的研發(fā)嚴(yán)格遵循重組蛋白制備的標(biāo)準(zhǔn)流程，從基因克隆、細(xì)胞表達(dá)到純化工藝均經(jīng)過優(yōu)化，確保產(chǎn)品具有批次間的一致性。其分子結(jié)構(gòu)經(jīng)過精準(zhǔn)設(shè)計，能夠特異性識別并結(jié)合靶標(biāo)抗原，為研究人員在探索生物分子相互作用、信號通路機(jī)制等方面提供有力工具。 在科研應(yīng)用中，H2A (CIT-013 Biosimilar Antibody)重組單克隆抗體可助力于疾病相關(guān)分子機(jī)制研究、生物標(biāo)志物發(fā)現(xiàn)以及藥物靶點驗證等前沿領(lǐng)域。通過與靶標(biāo)分子的特異性結(jié)合，可實現(xiàn)對目標(biāo)蛋白的定性、定量分析及亞細(xì)胞定位研究，為深入解析生命活動規(guī)律提供關(guān)鍵實驗數(shù)據(jù)支持。該產(chǎn)品僅用于實驗室研究，不用于臨床診斷或治療用途。

#N A

H2A

Human

Recombinant Human H2A protein

Homo sapiens (Human)

Non-conjugated

Monoclonal

It differs from different batches. Please contact us to confirm it.

0.01M PBS，pH7.4

Liquid

Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

3-4 weeks

It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.